Figure 1From: p21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancer Immunohistochemical staining of p21 and CD166 (x400). A) Staining intensity of p21 B) Staining intensity of CD166.Back to article page